Navigation Links
Proper Validation of Generic Drugs Could Save Millions of AIDS Patients

Increasing criticism is faced by AIDS generic drugs usage to treat HIV infections, due to non-compliance with clinical and laboratory procedures and data handling. Recently, the use of Anti-HIV single dose drug // Nevirapine which is used for the prevention of mother to child transmission is very much questioned of its effect.

Though Generic drugs is used by the large population of people during epidemics, due to its low cost formulations, which is useful for the treatment of millions of people as a life saving drug, there are evidence that generic drugs are as safe and as effective as branded drugs. In Brazil massive use of generic drug treatment as reduced HIV mortality.

Some critics point out that generic drugs are not monitored and tested properly as branded drugs produced by global pharmaceutical companies and comment generic drugs as “dubious”, “cheap”, and “deadly”, though it is commented by some critics in reality generic drugs offer the most affordable and best treatment for infected people in developing countries.

It is the fundamental right of the patient to know what drug they are taking and how effective and safe the drug is, and the patient should be aware that unsafe drugs could cause drug resistance and new strains of virus could emerge. Generic drug manufacturers are mostly from the Asian countries, there are 27 manufacturers in Asian countries, mostly they are produced for domestic uses and some drugs are exported, the countries mostly manufacturing generic drugs are China, India, and Thailand. The manufacturing companies are wholly or partly owned by the government enterprises, and these companies can simply sell drugs to their own government, fostering an intimacy between manufacturers and governments.

A system of drug monitoring of generic drugs is required, by which a network of clinical laboratory is to be linked to the generic drugs for its testing and validation before marketing of the product simi lar to the FDA or WHO and the monitoring should be a continuous process so that he quality of the drug produced should be monitored to find if there is fluctuation over time without vigilant testing. By this way if the generic drug produced is maintained in a standard to that of branded drugs, the amount of investment which is spent on the branded drugs would be saved enormously, and if proper system is maintained in monitoring and validation of generic drugs it would be very much useful for patients in developing and underdeveloped countries as it would offer an affordable and effective treatment to the affected patients, as the HIV-infected population is continuously climbing and it is estimated that 6 million HIV patients will die without immediate access to antiretroviral drugs.

Source: The Lanet.

Related medicine news :

1. Compounds Found In The Vegetable Broccoli Could Have Anti-Cancer Properties
2. Geriatric Patients With Chronic Kidney Disease May Not Be Treated Properly
3. Stem Cells, Tumor Cells Share Similar Properties: Scope For Treatment and Prevention?
4. Fruits And Vegetables Have Arthritis Risk Reducing Property
5. Proper Treatment of Hypothyroidism Found To Prevent Heart Diseases
6. Colon Cancer Patients Not Receiving Proper Treatment
7. Proper Diet Can Counter Macular Degeneration
8. Scots Do Not Have Access To Proper Dental Care
9. Risk Of Stroke Can Be Lessened By Proper Diet
10. Cancer-causing Property Of Teflon Leaves US Regulators Concerned
11. Anticancer Properties of Vitamin D Could Be Separated From Other Functions
Post Your Comments:

(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of ... award to iHire in recognition of their exemplary accomplishments in worksite health promotion. , ... Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, ... economy by obtaining investment capital for emerging technology companies. SCP has delivered ... already resulted in more than a million dollars of capital investment for five ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Collagen Matrix, Inc., ("Collagen ... and manufacturing of collagen and mineral based medical ... that Bill Messer has joined the ... further leverage the growing portfolio of oral surgery, ... Bill joins the Collagen Matrix executive team ...
(Date:6/24/2016)... ALEXANDRIA, Va. , June 24, 2016 ... a set of recommendations that would allow ... information (HCEI) with entities that make formulary and coverage ... determine the "value" of new medicines. The ... that does not appear on the drug label, a ...
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
Breaking Medicine Technology: